CSPC Pharmaceutical Group Limited — Earnings Release 2002

Mar 25, 2003

Listed Company Information

CHINA PHARMA<01093> - Results Announcement China Pharmaceutical Enterprise and Investment Corp Ltd announced on 25/03/2003: (stock code: 01093 ) Year end date: 31/12/2002 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/01/2002 from 01/01/2001 to 31/12/2002 to 31/12/2001 Note ($ ) ($ ) Turnover : 1,625,130,000 1,168,244,000 Profit/(Loss) from Operations : 297,891,000 192,819,000 Finance cost : (26,682,000) (27,102,000) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : 7,916,000 5,183,000 Profit/(Loss) after Tax & MI : 228,142,000 140,006,000 % Change over Last Period : +63 % EPS/(LPS)-Basic (in dollars) : 0.1662 0.1129 -Diluted (in dollars) : 0.1635 0.111 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 228,142,000 140,006,000 Final Dividend : 6.0 cents 3.6 cents per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : 16/04/2003 to 24/04/2003bdi. Payable Date : 15/05/2003 B/C Dates for Annual General Meeting : 16/04/2003 to 24/04/2003bdi. Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. Profit from operations 2002 2001 HK$ HK$ Profit from operations has been arrived at after charging (crediting): Amortisation of intangible assets 14,303,000 15,255,000 Allowance for doubtful debts 14,276,000 9,600,000 Depreciation of property, plant and equipment 103,818,000 88,715,000 Major overhaul expenses 28,591,000 - Bank interest income (1,737,000) (1,238,000) Interest income from loan receivables (504,000) (900,000) ======== ======== 2. Earnings per share The calculation of the basic and diluted earnings per share is based on the following data: 2002 2001 Profit attributable to shareholders HK$228,142,000 HK$140,006,000 ============== ============== Weighted average number of ordinary shares for the purpose of basic earnings per share 1,373,033,290 1,240,447,279 Effect of dilutive potential ordinary shares in respect of share options 22,612,855 20,934,321 ______________ ______________ Weighted average number of ordinary shares for the purpose of diluted earnings per share 1,395,646,145 1,261,381,600 ============= =============